Authors
Latest:
The subthreshold laser’s role in retinal vascular diseaseCombination therapy benefits from laser in the mix for DME, other conditions
Latest:
Laser therapy may offer fast-acting option for CSR resolutionPatients tolerate therapy well; high safety profile allows re-treatment as necessary
Latest:
Update on FDA approval of XIPERE for macular edema associated with uveitis from Bausch + LombBausch + Lomb's Yolande Barnard shares an update on the FDA approval of XIPERE for the treatment of macular edema associated with uveitis.
Latest:
Comparing suitable naïve versus pre-treated DME patientsJavier Zarranz-Ventura MD, PhD, FEBO, discusses the key highlights from his presentation on a clinical investigation of suitable naïve versus pre-treated DME patients, and what it means for future research.
Latest:
Waiting on a treatment: How the history of MacTel is leading us into the future“Our current understanding of the pathophysiological basis of MacTel has led to the development of novel therapeutic approaches that may be able to break ground in this disease state.”
Latest:
FISH in focus for fast eye infection diagnosisDespite cost, advantages include sensitivity, improved outcomes
Latest:
ST laser therapy may reduce DME intravitreal injectionsUsed as an adjunct, ST laser therapy may reduce the treatment burden for patients while maintaining visual acuity.
